📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group. (2014)

First Author: Ng CS

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00228-014-1703-0

PubMed Identifier: 24888881

Publication URI: http://europepmc.org/abstract/MED/24888881

Type: Journal Article/Review

Volume: 70

Parent Publication: European journal of clinical pharmacology

Issue: 9

ISSN: 0031-6970